<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE nitf SYSTEM "http://www.nitf.org/IPTC/NITF/3.3/specification/dtd/nitf-3-3.dtd">
<nitf change.date="June 10, 2005" change.time="19:30" version="-//IPTC//DTD NITF 3.3//EN">
  <head>
    <title>Prescription Drugs</title>
    <meta content="L05FDA" name="slug"/>
    <meta content="5" name="publication_day_of_month"/>
    <meta content="7" name="publication_month"/>
    <meta content="2000" name="publication_year"/>
    <meta content="Wednesday" name="publication_day_of_week"/>
    <meta content="Editorial Desk" name="dsk"/>
    <meta content="16" name="print_page_number"/>
    <meta content="A" name="print_section"/>
    <meta content="4" name="print_column"/>
    <meta content="Opinion" name="online_sections"/>
    <docdata>
      <doc-id id-string="1212545"/>
      <doc.copyright holder="The New York Times" year="2000"/>
      <identified-content>
        <classifier class="indexing_service" type="descriptor">Drugs (Pharmaceuticals)</classifier>
        <classifier class="indexing_service" type="descriptor">Regulation and Deregulation of Industry</classifier>
        <org class="indexing_service">Food and Drug Administration</org>
        <person class="indexing_service">Thomas, Nigel</person>
        <classifier class="online_producer" type="types_of_material">Letter</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion/Opinion/Letters</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion/Opinion</classifier>
        <classifier class="online_producer" type="general_descriptor">Regulation and Deregulation of Industry</classifier>
        <classifier class="online_producer" type="general_descriptor">Drugs (Pharmaceuticals)</classifier>
        <classifier class="online_producer" type="general_descriptor">Medicine and Health</classifier>
      </identified-content>
    </docdata>
    <pubdata date.publication="20000705T000000" ex-ref="http://query.nytimes.com/gst/fullpage.html?res=9503E3DD1339F936A35754C0A9669C8B63" item-length="128" name="The New York Times" unit-of-measure="word"/>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>Prescription Drugs</hl1>
      </hedline>
      <abstract>
        <p>Nigel Thomas letter approves FDA decision to consider whether some prescription drugs should be change to over-the-counter status</p>
      </abstract>
    </body.head>
    <body.content>
      <block class="lead_paragraph">
        <p>To the Editor:</p>
        <p>The decision by the Food and Drug Administration to consider whether some prescription drugs should be changed to over-the-counter status (news article, June 28) is overdue.</p>
        <p>Internet pharmacies now account for a growing percentage of prescriptions filled annually in the United States. A significant proportion of these sales are completed without valid prescriptions.</p>
      </block>
      <block class="full_text">
        <p>To the Editor:</p>
        <p>The decision by the Food and Drug Administration to consider whether some prescription drugs should be changed to over-the-counter status (news article, June 28) is overdue.</p>
        <p>Internet pharmacies now account for a growing percentage of prescriptions filled annually in the United States. A significant proportion of these sales are completed without valid prescriptions.</p>
        <p>The White House proposals late last year to bolster the F.D.A.'s regulation of Internet pharmacies as a way of dealing with this problem does not address the root issue: we hate gatekeepers; we like self-care.</p>
        <p>The new initiative recognizes this reality.</p>
        <p>NIGEL THOMAS  New York, June 29, 2000</p>
      </block>
    </body.content>
  </body>
</nitf>
